Emir Muzurović

1. MUZUROVIĆ, Emir, COJIĆ, Milena, STANKOVIĆ, Zoja, JANEŽ, Andrej. Epicardial adipocyte-derived TNF-α modulates local inflammation in patients with advanced coronary artery disease. Current vascular pharmacology. 2022, vol. 20, iss. 1, str. 94-95. ISSN 1570-1611. DOI: 10.2174/157016112001211228145754. [COBISS.SI-ID 92811267]

2. MUZUROVIĆ, Emir, VOLČANŠEK, Špela, ZIBAR TOMŠIĆ, Karin Zibar, JANEŽ, Andrej, MIKHAILIDIS, Dimitri P, RIZZO, Manfredi, MANTZOROS, Christos S. Glucagon-like peptide-1 receptor agonists and dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 receptor agonists in the treatment of obesity/metabolic syndrome, prediabetes/diabetes and non-alcoholic fatty liver disease—current evidence. Journal of cardiovascular pharmacology and therapeutics. [Online ed.]. 2022, vol. 27, str. 1-22, ilustr. ISSN 1940-4034. https://journals.sagepub.com/doi/epdf/10.1177/10742484221146371, DOI: 10.1177/10742484221146371. [COBISS.SI-ID 135187459]

3. JANEŽ, Andrej (author, corresponding author), MUZUROVIĆ, Emir, PANTEA STOIAN, Anca, HALUZIK, Martin, GUJA, Cristian, CZUPRYNIAK, Leszek, SMIRČIĆ-DUVNJAK, Lea, LALIĆ, Nebojsa M., TANKOVA, Tsvetalina, FRAS, Zlatko, et al. Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice : recommendations from a Eastern and Southern Europe diabetes expert group. International journal of cardiology. [Print ed.]. 2022, vol. 365, str. 8-18, ilustr. ISSN 0167-5273. https://www.sciencedirect.com/science/article/pii/S0167527322010853, DOI: 10.1016/j.ijcard.2022.07.017. [COBISS.SI-ID 116727811]

4. SALMEN, Teodor, SERBANOIU, Liviu-Ionut, BICA, Ioana-Cristina, SERAFINCEANU, Cristian, MUZUROVIĆ, Emir, JANEŽ, Andrej, BUSNATU, Stefan, BANACH, Maciej, RIZVI, Ali Abbas, RIZZO, Manfredi, PANTEA STOIAN, Anca. A critical view over the newest antidiabetic molecules in light of efficacy - a systematic review and meta-analysis. International journal of molecular sciences. 2023, vol. 24, iss. 11, [article no.] 9760, str. 1-16, ilustr. ISSN 1422-0067. https://www.mdpi.com/1422-0067/24/11/9760, DOI: 10.3390/ijms24119760. [COBISS.SI-ID 154457347]

5. BICA, Ioana-Cristina, STOICA, Roxana Adriana, SALMEN, Teodor, JANEŽ, Andrej, VOLČANŠEK, Špela, POPOVIC, Djordje S., MUZUROVIĆ, Emir, RIZZO, Manfredi, PANTEA STOIAN, Anca. The effects of sodium-glucose cotransporter 2-inhibitors on steatosis and fibrosis in patients with non-alcoholic fatty liver disease or steatohepatitis and type 2 diabetes : a systematic review of randomized controlled trials. Medicina. 2023, vol. 59, iss. 6, [article no.] 1136, str. 1-15, ilustr. ISSN 1648-9144. https://www.mdpi.com/1648-9144/59/6/1136, DOI: 10.3390/medicina59061136. [COBISS.SI-ID 155373315]

6. ZEČEVIĆ, Ksenija, VOLČANŠEK, Špela, KATSIKI, Niki, RIZZO, Manfredi, MILIČEVIĆ MILARDOVIĆ, Tanja, PANTEA STOIAN, Anca, BANACH, Maciej, MUZUROVIĆ, Emir. Maturity-onset diabetes of the young (MODY) - in search of ideal diagnostic criteria and precise treatment. Progress in cardiovascular diseases. Jul./Aug. 2024, vol. 85, str. 14-25, ilustr. ISSN 1873-1740. https://www.sciencedirect.com/science/article/pii/S0033062024000495?via%3Dihub, DOI: 10.1016/j.pcad.2024.03.004. [COBISS.SI-ID 197182979]

7. JANEŽ, Andrej, MUZUROVIĆ, Emir, BOGDANSKI, Pawel, CZUPRYNIAK, Leszek, FABRYOVA, Lubomira, FRAS, Zlatko, GUJA, Cristian, HALUZIK, Martin, KEMPLER, Peter, LALIĆ, Nebojsa M., et al. Modern management of cardiometabolic continuum : from overweight/obesity to prediabetes/type 2 diabetes mellitus. recommendations from the Eastern and Southern Europe Diabetes and Obesity Expert Group. Diabetes therapy. 2024, vol. 15, no. 9, str. 1865-1892. ISSN 1869-6961. https://link.springer.com/article/10.1007/s13300-024-01615-5, DOI: 10.1007/s13300-024-01615-5. [COBISS.SI-ID 203973635]

8. VOLČANŠEK, Špela, JANEŽ, Andrej, RIZZO, Manfredi, MUZUROVIĆ, Emir (author, corresponding author). Monitoring the liver as a part of the cardio-renal-metabolic continuum : what is cooking and burning with non-invasive tests and treatment options?. Journal of diabetes and its complications. Dec. 2024, vol. 38, iss. 12, str. 1-3, ilustr. ISSN 1056-8727. https://www.sciencedirect.com/science/article/abs/pii/S1056872724002010?via%3Dihub#preview-section-abstract, DOI: 10.1016/j.jdiacomp.2024.108875. [COBISS.SI-ID 209949955]

9. KOKKORAKIS, Michail, MUZUROVIĆ, Emir, VOLČANŠEK, Špela, CHAKHTOURA, Marlene, HILL, Michael A., MIKHAILIDIS, Dimitri P, MANTZOROS, Christos S. Steatotic liver disease : pathophysiology and emerging pharmacotherapies. Pharmacological reviews. 2024, vol. 76, iss. 3, str. 454-499, ilustr. ISSN 1521-0081. https://pharmrev.aspetjournals.org/content/76/3/454, DOI: 10.1124/pharmrev.123.001087. [COBISS.SI-ID 194898435]

10. VOLČANŠEK, Špela, KOCEVA, Andrijana, JENSTERLE SEVER, Mojca, JANEŽ, Andrej, MUZUROVIĆ, Emir (author, corresponding author). Amylin : from mode of action to future clinical potential in diabetes and obesity. Diabetes therapy. 2025, vol. 16, no. 6, str. 1207-1227, ilustr. ISSN 1869-6961. https://link.springer.com/article/10.1007/s13300-025-01733-8, DiRROS - Digital repository of Slovenian research organizations, DOI: 10.1007/s13300-025-01733-8. [COBISS.SI-ID 235117315]

11. VOLČANŠEK, Špela, MUZUROVIĆ, Emir. Epicardial adipose tissue modulation : a new horizon for sodium-glucose cotransporter 2 inhibitors. Current vascular pharmacology. 2025, no. 4, vol. 23, str. 231 - 232. ISSN 1875-6212. DOI: 10.2174/0115701611393796250313063902. [COBISS.SI-ID 241425411]

12. KRALJEVIĆ, Ivana, SOLAK, Mirsala, MANDIĆ, Ante, MLEKUŠ, Katarina, RAIČEVIĆ, Maja, DIVANOVIĆ SLATO, Anida, KOVAČEVIĆ, Zlata, MUZUROVIĆ, Emir. Hypopituitarism and cardiovascular risk. Journal of cardiovascular pharmacology and therapeutics. [Online ed.]. 2025, vol. 30, str. 1-22, ilustr. ISSN 1940-4034. https://journals.sagepub.com/doi/10.1177/10742484251332398, Repository of the University of Ljubljana – RUL , DiRROS - Digital repository of Slovenian research organizations, DOI: 10.1177/1074248425133239. [COBISS.SI-ID 275553027]

13. MUZUROVIĆ, Emir, KATSIKI, Niki, VOLČANŠEK, Špela, PLESCIA, Fulvio, RIZZO, Manfredi, MANTZOROS, Christos S. Emerging incretin- and multi-agonist-based treatments – the continued refinement and continuous expansion of a potent therapeutic armamentarium for cardio-kidney-liver-metabolic diseases and beyond. Metabolism, clinical and experimental. 2026, vol. 177, [article no.] 156494, str. 1-35, ilustr. ISSN 1532-8600. DOI: 10.1016/j.metabol.2026.156494. [COBISS.SI-ID 267941123]

14. MUZUROVIĆ, Emir, KRALJEVIĆ, Ivana, VOLČANŠEK, Špela. Letter : metabolic dysfunction-associated steatotic liver disease : a silent whisper to the heart?. Angiology. [Online ed.]. 2026, vol. 77, issue 8, str. 1073-1074. ISSN 1940-1574. https://journals.sagepub.com/doi/10.1177/00033197251407732, DOI: 10.1177/00033197251407732. [COBISS.SI-ID 268018179]

15. MILIČEVIĆ MILARDOVIĆ, Tanja, CVITKOVIĆ, Ivna, VOLČANŠEK, Špela, KATSIKI, Niki, MIKHAILIDIS, Dimitri P., PATOULIAS, Dimitrios, MUZUROVIĆ, Emir. Obese and overweight patients with type 2 diabetes mellitus are not treated optimally - an overview of current clinical practice and future perspectives. Expert review of clinical pharmacology. 2026, vol. 19, issue 7, str. 671-686, ilustr. ISSN 1751-2441. https://www.tandfonline.com/doi/full/10.1080/17512433.2026.2706660, DOI: 10.1080/17512433.2026.2706660. [COBISS.SI-ID 286533379]